tirzepatide vs semaglutide chemical structure Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review Overview of Tirzepatide and Semaglutide

The FDA has stated that compounded drugs "are not FDA-approved" and that companies should not "try to compound drugs in a way that circumvents FDA's approval process." Additionally, the Novo Nordisk patent litigation against Hims & Hers in early 2026 - which ultimately resulted in a partnership agreement - and a coalition letter from 35 state attorneys general about AI-generated weight-loss advertising both signal that the regulatory and legal landscape for compounded telehealth products continues to evolve

Gopi, S

PE, permeation enhancer

Knowing which ones to steer clear of is key to managing your condition well

FDA Adds New Warning to GLP-1 Drugs